Baillie Gifford & Co
MDLN

Baillie Gifford & Co’s Medline Inc MDLN Stock Holding History

Baillie Gifford & Co’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447M Buy
11,343,036
+1,367,261
+14% +$55.1M 0.41% 54
2026
Q1 		$444M Sell
9,975,775
-434,596
-4% -$19.2M 0.45% 46
2025
Q4 		$437M Buy
+10,410,371
New +$440M 0.36% 54

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Baillie Gifford & Co's MDLN Position: Q2 2026 in Review

Baillie Gifford & Co increased its Medline Inc (MDLN) stake by 14% in Q2 2026, buying an estimated $55.1M and bringing the position to 11,343,036 shares worth $447M. The position accounts for 0.41% of the portfolio, ranked #54.

Baillie Gifford & Co first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Baillie Gifford & Co held 11,343,036 shares of Medline Inc worth $447M as of Q2 2026.
  • Baillie Gifford & Co bought 1,367,261 Medline Inc shares in Q2 2026, an estimated $55.1M.
  • Medline Inc made up 0.41% of Baillie Gifford & Co's portfolio in Q2 2026, its #54 holding.
  • Baillie Gifford & Co first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.